Most glomerulonephritides, even the more common types, are rare diseases. They are
nevertheless important since they frequently affect young people, often cannot be cured, and …

Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …

Primary forms of minimal change disease and focal segmental glomerulosclerosis are rare
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …

The outcome of steroid-dependent or frequently relapsing nephrotic syndrome of minimal
change disease (MCD), mesangial proliferative GN (MesGN), or FSGS may be poor and …

Most glomerular diseases are immunologically mediated disorders of the kidney and are
common causes of ESKD. In addition to supportive therapy, a wide range of …

Background Use of rituximab (RTX) for focal segmental glomerulosclerosis (FSGS) and
minimal change disease (MCD) is widely described in children. Clinical evidence in adults is …

Abstract Rituximab (RTX), a chimeric, monoclonal anti-CD20 antibody, is increasingly used
in immune-mediated renal diseases. While licensed in the induction treatment of ANCA …

Background Few studies have examined the treatment and outcome of adult-onset minimal
change nephrotic syndrome (MCNS). We retrospectively studied 125 patients who had …

Minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) are
glomerulopathies associated with nephrotic syndrome. Primary forms of these diseases are …

Background Recent years have seen increasing use of rituximab (RTX) for various types of
primary and secondary glomerulopathies. However, there are no studies that specifically …